Received Jan 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included varicella zoster vaccine with an associated reaction of pain (received first dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: painful). Rechallenge with Shingles vaccine was positive. The outcome of the pain was not reported. It was unknown if the reporter considered the pain to be related to Shingles vaccine. It was unknown if the company considered the pain to be related to Shingles vaccine. Linked case(s) involving the same patient: US2026AMR002819 Additional Information: GSK Receipt Date: 06-JAN-2026 This case was reported by a patient via interactive digital media. Patient stated that the vaccine was more painful than the first one. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: US-GSK-US2026AMR002819:first dose